Title |
Giant Cell Tumor of the Lateral Skull Base: Diagnostic and Management Options
|
---|---|
Published in |
Journal of Neurological Surgery REPORTS, May 2018
|
DOI | 10.1055/s-0038-1645885 |
Pubmed ID | |
Authors |
Nicholas T. Gamboa, Brenden Ronna, Christina T. Gamboa, Cheryl A. Palmer, Min S. Park, Richard K. Gurgel, William T. Couldwell, M. Yashar S. Kalani |
Abstract |
Giant cell tumor of bone (GCTB) is a rare, benign, osteolytic neoplasm that most commonly occurs in early adulthood and often involves the long bones of the body. Although GCTB largely affects the epiphyses of long bones, several reports of GCTB involvement of the cranial and facial bones exist in the literature. In addition to reviewing other reported cases of GCTBs of the lateral skull base in the literature, the authors report here on the clinical presentation, radiographic findings, and neurosurgical management of a patient found to have a GCTB of the middle and infratemporal fossae, which was treated by aggressive en bloc resection of the lateral skull base. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 12 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 2 | 17% |
Student > Doctoral Student | 2 | 17% |
Other | 2 | 17% |
Professor | 1 | 8% |
Unknown | 5 | 42% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 4 | 33% |
Psychology | 1 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 8% |
Unknown | 6 | 50% |